Dr. Agenor Limon presents research integrating functional metrics with large anatomical, transcriptomic, and proteomic datasets to evaluate the relationship between synaptic E/I ratio and behavioral abnormalities across postmortem intervals and brain banks.
Alterations in synaptic function have been found in transcriptomic, genetic, and proteomic studies of neurological and mental disorders. Clinical and preclinical studies suggest that synaptic dysfunction and behavioral abnormalities in disorders like Alzheimer’s disease and schizophrenia may be mechanistically linked to the emergence of imbalances between excitatory (E) and inhibitory (I) receptors. However, until recently, the electrophysiological E/I synaptic ratio had only been measured in animal models.
Using pioneering methods developed in the lab including reactivation and microtransplantation of synaptic receptors from frozen human brains, Dr. Agenor Limon’s research team has obtained electrophysiological metrics of global synaptic E/I ratios in cortical brain regions of subjects that were affected by Alzheimer’s Disease and synaptic measurements in schizophrenia.
In this webinar, Dr. Agenor Limon will present recent research integrating functional metrics with large anatomical, transcriptomic, and proteomic datasets to evaluate the relationship between synaptic E/I ratio and behavioral abnormalities across postmortem intervals and brain banks.
Key Topics Include:
- Understand the global synaptic excitation to inhibition ratio between excitatory and inhibitory synaptic receptors determined from reactivated frozen human brain tissue
- Understand the relationship between electrophysiological metrics of receptor function and multi-omic data in neurodegenerative disorders
- Understand the role of deviations of the excitation to inhibition ratio with clinical presentation in Alzheimer’s disease
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Electrophysiology of Human Native Receptors in Neurological and Mental Disorders
1. Electrophysiology of Human
Native Receptors in Neurological
and Mental Disorders
Agenor Limon, PhD
Assistant Professor
Department of Neurology
Mitchell Center for Neurodegenerative Diseases
aglimonr@utmb.edu
2. Electrophysiology of Human
Native Receptors in Neurological
and Mental Disorders
Dr. Agenor Limon presents research
integrating functional metrics with large
anatomical, transcriptomic, and proteomic
datasets to evaluate the relationship between
synaptic E/I ratio and behavioral abnormalities
across postmortem intervals and brain banks.
3. Copyright 2021 A. Limon and InsideScientific. All rights reserved.
Electrophysiology of Human
Native Receptors in Neurological
and Mental Disorders
Agenor Limon, PhD
Assistant Professor
Department of Neurology
Mitchell Center for Neurodegenerative Diseases
aglimonr@utmb.edu
4. Overview
• The problem of understanding synaptic dysfunction in
human disorders.
• Microtransplantation of Synaptic Receptors.
• Integration of excitatory AMPA receptors with multiomics
data in schizophrenia.
• Excitation to Inhibition balance in across brain regions in
Alzheimer’s disease.
4
5. Overview
• The problem of understanding synaptic dysfunction in
human disorders.
• Microtransplantation of Synaptic Receptors.
• Integration of excitatory AMPA receptors with multiomics
data in schizophrenia.
• Excitation to Inhibition balance in across brain regions in
Alzheimer’s disease.
5
9. Healthy twin Twin
with schizophrenia
Wooley and McGuire, 2005
Healthy brain Advanced AD
9
10. * Cognition is preserved despite substantial cortical
thinning along life span.
* Brain reorganization and plasticity overcomes cognitive
damage from acute and extensive brain destruction.
From Fjell et al., 2015 From Kliemann et al., 2019 10
11. • How to study functional alterations in the
neurotransmitter receptors that are
fundamental for neuronal activity and the
target of toxic oligomers?
11
12. 12
Zhao Y. et al. – Science - 2019
Differences:
• Arrangement of the subunits to form
the receptor
• Auxiliary subunits
• Subunits ratio abundance
(across brain region and ontogeny)
• transmembrane AMPA receptor regulatory proteins (TARPs)
• cornichon homologues (CNIHs)
• cysteine-knot AMPAR modulating proteins 44 (CKAMP44)
• germ cell-specific gene 1-like (GSG1L) protein.
Shen K. And Zeppillo T. et al –Scientific Report journal
Native AMPAr vs Recombinant
rGluA2-GluA3
Native Recombinant
13. Overview
• The problem of understanding synaptic dysfunction in
human disorders.
• Microtransplantation of Synaptic Receptors.
• Integration of excitatory AMPA receptors with multiomics
data in schizophrenia.
• Excitation to Inhibition balance in across brain regions in
Alzheimer’s disease.
13
17. Overview
• The problem of understanding synaptic dysfunction in
human disorders.
• Microtransplantation of Synaptic Receptors.
• Integration of excitatory AMPA receptors with multiomics
data in schizophrenia.
• Excitation to Inhibition balance in across brain regions in
Alzheimer’s disease.
17
18. From Glantz and Lewis (2000)
Loss of spine density in schizophrenia
18
21. AMPA receptors in Schizophrenia
Zeppillo et al., Schiz Res, 2020
*
21
22. Proteins positively correlated with AMPA receptor
current in human synaptosome (P2) preparations
Zeppillo et al., Schiz Res, 2020
Ribosomal
proteins
External
membrane
Mitochondrial
proteins
Inner membrane
Mitochondrial
proteins
AMPA receptor
subunits
22
23. Proteins negatively correlated with AMPA receptor
current in human synaptosome (P2) preparations
Traffic, folding and signaling proteins
23
24. Zeppillo et al., Schiz Res, 2020
Genes downregulated in SZ.
Proteins downregulated in SZ.
Proteins (-) r with AMPA responses in SZ.
Multifactorial convergence on synaptic dysfunction
24
25. Directionality of signaling pathways on synaptic function
Zeppillo et al., Schiz Res, 2020
From Glantz and Lewis (2000)
25
26. • AMPA receptors from frozen brains can be reactivated
and recorded by TEVC.
• Amplitude of synaptic receptors’ currents correlate
with synaptic elements at the proteomic level.
• Function of receptors provide global directionality to
signaling pathways that are commonly found altered
in brain disorders.
26
27. Overview
• The problem of understanding synaptic dysfunction in
human disorders.
• Microtransplantation of Synaptic Receptors.
• Integration of excitatory AMPA receptors with multiomics
data in schizophrenia.
• Excitation to Inhibition balance in across brain regions in
Alzheimer’s disease.
27
28. From Boros et al., 2017, Barral and Reyes 2016
Glutamatergic and GABAergic synapses
Principal postsynaptic receptors
A
B
How is the E/I balance in brain disorders?
28
29. • Can we use MSM to measure global excitation
to inhibition balance in brain disorders?
29
30. Ze
Scaduto et al., Sci Rep 2020
Preserved E/I Balance in Human Cx after long PMI
30
31. Modified from La Ferla & Oddo, 2005, Alzheimer’s Association 2007, Boros et al., 2017
AD neuropathological change
31
32. Sperling et al., 2009
Reduced deactivation of the DMN is observed
in old individuals with no Ab burden
32
33. Celone et al., 2006,
Pihlajamaki et al., 2008
Sperling et al., 2009
Paradoxical increase of the DMN is observed
in old individuals with no Ab burden
33
34. Determination of global synaptic anatomical
and electrophysiological E/I in AD
Parietal Cortex
Aβ accumulation
Sperling et al., 2009
34
35. FDT analysis of anatomical E/I ratio
Lauterborn et al, Nat Comm, 2021
35
36. No changes in total synaptic density but shifts
from high to low PSDs intensity in AD and DS
Lauterborn et al, Nat Comm, 2021
36
38. 38
Global E/I balance in AD
Frontal Cortex
Parietal Cortex
Medial
Temporal Cortex Hippocampus
Aβ accumulation Hyperactivation Reduction of Glu
activity
First areas affected by the pathology
39. Global eE/I balance in Health
Frontal Cortex
Parietal Cortex
Medial
Temporal Cortex Hippocampus
E/I
ratio
Singh A. … Scaduto P. et al.
accepted - Journal of
Alzheimer's Disease 2020
Lauterborn J. and Scaduto P. et al.
Nature Communications 2021 Scaduto P. et al. in preparation
39
40. eE/I imbalance in AD
p=0.039
p=0.0296
Frontal Cortex
Parietal Cortex
Medial
Temporal Cortex Hippocampus
E/I
ratio
Singh A. … Scaduto P. et al.
accepted - Journal of
Alzheimer's Disease 2020
Lauterborn J. and Scaduto P. et al.
Nature Communications 2021 Scaduto P. et al. in preparation
p=0.041
40
44. 1. The PCx and TCx in AD show strong loss of excitatory
and inhibitory synapses
2. The impairment of synapses is unequal leading to
increased transcriptional, anatomical and functional E/I
synaptic imbalance
3. Pro-excitatory imbalance in AD may explain the
hyperexcitability observed in the DMN, which at early stages
interferes with the encoding of memory, and promotes
activity-dependent release of Ab and Tau oligomers
44
46. Thanks!
Collaborators:
Julie Lauterborn, Adolfo Sequeira, Mark Vawter at UCI
David Cotter, Melanie Focking at RCSI
Dirk Keene at University of Washington
Giulio Taglialatela, Rakez Kayed and Balaji Krishnan at UTMB
Limon Lab:
Tommaso Zeppillo
Pietro Scaduto
Kevin Shen
https://www.utmb.edu/mitchellcenter/lab-groups/agenor-limon 46
47. Thanks for participating!
Before you go…
• Complete the Survey! We’d love to get your feedback
• Still have a question? Use the Ask a Question panel
• Want to learn more about Multi Channel Systems’
electrophysiology instrumentation?
Visit: www.multichannelsystems.com
Editor's Notes
During all our life we consistently lose neurons and synaptic complexity with only mild changes in cognitive function. We can lose a third of or cortical thikness and still live a normal life. Every man in purple and women in green across life in cognitively normal people.
For example kids or teenagers that undergo complete resection of half the brain, due to intractable epilepsy can see only a mild to moderate loss of cognitively function. Even when the left hemisphere is removed. This is quite remarkable since major areas associated with speech are in the left hemisphere. But reorganization of the right hemisphere allow to remergence of speech. While persistent epilepsy produces cognitive impairment, the loss of half of the brain has only a moderate effect on cognition. Actually people with only half the brain go on to have functional and successful lives.
Auxiliary subunits play a critical role in the facilitation and regulation
To gather this information, we used the microtransplantation of synaptic membranes method (MSM). Briefly, synaptosomes are isolated from frozen tissue, the synaptosomes are lised to form small vesicles that containing the human membranes with their receptors and synaptic complexes, and these protoeliposomes are injected into Xenopus oocytes,
which are 1mm in diameter and strong enough to resist the process. The human membranes fuse with the membrane of the oocyte and then we can apply agonists of the receptors to observe their responses.
Xenopus oocytes do not express endogenous GABA or glutamate receptors, therefore responses elicited by the agonists are mediated by microtransplanted human receptors. 45 s
For these experiments we used frozen DLPFC of 10 CTRL and 10 SZ matched by Age, PMI, and as closely as possibly by pH and RIN.
There was a slight statistically significant difference in pH and RIN between CTRL and SZ.
This parameters were included as covariates in the analysis of the data.
Enriched synaptosomal preparations from the DLPFC were used for MSM experiments and for label free proteomic analysis.
An adjacent dlpfc section was used for RNA Seq. RNA seq
The severe cognitive impairment and disability observed in patients with AD is a logical consequence of the loss of brain volume at late stages of AD. Postmortem analysis show substantial loss of gray and white matter and the presence of the neuropathological change that define AD: which is he presence of Amyloid plaques and neurofibrillary tangles. Many decades of research have consistently show that the loss of dendritic spines and synaptic density is the best correlate of cognitive impairment. However, it is important to note that loss of neurons or even loss of brain regions does not necessarily mean loss of cognitive function. For example.
The severe cognitive impairment and disability observed in patients with AD is a logical consequence of the loss of brain volume at late stages of AD. Postmortem analysis show substantial loss of gray and white matter and the presence of the neuropathological change that define AD: which is he presence of Amyloid plaques and neurofibrillary tangles. Many decades of research have consistently show that the loss of dendritic spines and synaptic density is the best correlate of cognitive impairment. However, it is important to note that loss of neurons or even loss of brain regions does not necessarily mean loss of cognitive function. For example.
M1-selective allosteric agonist, is effective in increasing spontaneous excitatory postsynaptic currents in the medial prefrontal cortex (mPFC) pyramidal cells and improving memory in a transgenic mouse model of AD
-Nicotinic Stimulation Produces Multiple Forms of Increased Glutamatergic Synaptic Transmission (nicotine-induced glutamate release in the prefrontal cortex)